Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Metallomics : Integrated Biometal Science|January 26, 2011
Characterization of the recombinant copper chaperone (CCS) from the plant Glycine (G.) maxSara Sagasti, Inmaculada Yruela, Maria Bernal, et al.European Journal of Biochemistry|October 18, 2002
Probing the role of glutamic acid 139 of Anabaena ferredoxin-NADP+ reductase in the interaction with substratesMerche Faro, Susana Frago, Tomas Mayoral, et al.Biophysical Chemistry|March 9, 2005
Towards a new interaction enzyme:coenzymeMarta Martínez-Júlvez, Jesús Tejero, José R Peregrina, et al.Biochemistry|September 1, 2005
The ferredoxin-NADP(H) reductase from Rhodobacter capsulatus: molecular structure and catalytic mechanismIsabel Nogués, Inmaculada Pérez-Dorado, Susana Frago, et al.Biochemistry|January 8, 2008
Flavodoxin-mediated electron transfer from photosystem I to ferredoxin-NADP+ reductase in Anabaena: role of flavodoxin hydrophobic residues in protein-protein interactionsGuillermina Goñi, Ana Serrano, Susana Frago, et al.Biochimica Et Biophysica Acta|November 11, 2009
Dual role of FMN in flavodoxin function: electron transfer cofactor and modulation of the protein-protein interaction surfaceSusana Frago, Isaias Lans, José A Navarro, et al.Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 30, 2010
Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetesNilani Jeyaratnaganthan, Kurt Højlund, Jens Peter Kroustrup, et al.Scientific Reports|August 8, 2019
Maternal transmission of an Igf2r domain 11: IGF2 binding mutant allele (Igf2r<sup>I1565A</sup>) results in partial lethality, overgrowth and intestinal adenoma progressionJennifer Hughes, Mirvat Surakhy, Sermet Can, et al.Biochemistry|May 19, 2004
Role of the C-terminal tyrosine of ferredoxin-nicotinamide adenine dinucleotide phosphate reductase in the electron transfer processes with its protein partners ferredoxin and flavodoxinIsabel Nogués, Jesús Tejero, John K Hurley, et al.Toxicology and Applied Pharmacology|May 13, 2024
Pharmacokinetics and safety of LEAD-452, an EGFR-specific 4-1BB-agonistic trimerbody in non-human primatesRocío Navarro, Susana Frago, Oana Hangiu, et al.Pageof 3